Contraceptive Technology: Quest for Excellence (CT Quest)

Venue: Hyatt Regency Atlanta

Location: Atlanta, Georgia, United States

Event Date/Time: Nov 03, 2011 End Date/Time: Nov 05, 2011
Report as Spam

Description

Overview
Conference Invitation
Dear Colleagues,

Once again, Contraceptive Technology: Quest for Excellence brings you an exciting agenda of need-to-know management updates on contraceptives and a variety of GYN conditions and problems. We give considerable attention this year to hormonal contraceptives, covering new formulations, efficacy, benefits and side effects. As always, we provide insight into how to manage the tricky problems you'll see first thing back in the office on Monday morning—pelvic pain, persistent vaginitis, abnormal breast findings, and LSIL and HSIL management, to name just a few.

Our speakers will bring you the state of the art, as well as the controversial practice tips: managing the side effects of long-acting reversible methods to help patients continue with these highly effective methods, how today's key study findings guide pill management, controversial issues related to adolescent contraception, as well as new breakthroughs in understanding how HIV is transmitted. You won't want to miss the STD Clinical Update Preconference, focusing on the highlights of the new STD Treatment Guidelines or the other interesting Preconferences. And where else will you learn about the more off-beat dilemmas you frequently encounter? The real low-down on Vitamin D, Omega-3, and other supplements, how the media influences adolescent sexual behavior, and discerning any significant difference among the myriad of combined pill formulations.

If this is your first Contraceptive Technology conference, we welcome you to join us and the other attendees, many of whom have come to a dozen or more of these conferences over the years. If this is your twelfth, seventh or third conference with us, we look forward to seeing you again and to having great conversation about the clinical challenges you face. Everyone has the opportunity to engage with the authors of the eponymous reference, Contraceptive Technology, and with the leading clinicians and researchers we've invited to present.

Last, and most critical, we guarantee that your conference experience will run seamlessly. Production value counts when you are investing limited funds and, even more, limited time. We look forward to seeing you at the year's best national family planning conference!

The Authors of Contraceptive Technology
Robert A. Hatcher, MD, MPH
Willard Cates, Jr., MD, MPH
Deborah Kowal, MA, PA
Anita L. Nelson, MD
Michael Policar, MD, MPH
James Trussell, PhD

Planning Committee Member
Carrie Cwiak, MD, MPH

Program Coordinator
Pam Jenkins-Wallace, MS, NP
Vice President, Program Development
Contemporary Forums

What You Will Learn
This program will enable you to better:

Fine-tune your contraceptive management skills, appropriately incorporating new options and prescribing regimens.
Recognize early signs and symptoms and discuss clinical management of common and complex challenges in women's health and primary care, including persistent vaginitis, abnormal breast findings, chronic pelvic pain, adolescent issues, abnormal pap and others.
Outline practical approaches for preventing unintended pregnancy.
Discuss the clinical management of common side effects of long-acting reversible contraception to maximize patient acceptance of these highly effective methods.
Examine typical routine screening tests done during well woman exams and identify protocols for appropriate care and best use of resources.
Describe media influence on adolescent sexual and other risk-taking behaviors and identify strategies for improving media literacy.
WHO SHOULD ATTEND?
Anyone involved in the care of high-risk newborns including:

Physicians
Nurse Practitioners
Pharmacists
Nurse-Midwives
Registered Nurses

Physician Assistants
Public Health Professionals
Researchers
Health Educators

Venue

265 Peachtree Street NE,
Atlanta
Georgia
United States
MORE INFO ON THIS VENUE